{
  "trial_id": "NCT01889134",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Clinical diagnosis of primary hyperparathyroidism",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Subjects able and willing to comply with the requirements of the protocol",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Other diseases and medications known to interfere with bone or mineral metabolism",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Evidence of active malignancy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Significant renal impairment as indicated by serum creatinine levels above the normalized range for age",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Significant hepatic dysfunction",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Malabsorption syndrome",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Active gastroduodenal ulcers",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Actual or planned pregnancy (in alendronate group females must not be planning to conceive during the two years following the study) or breast-feeding",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "The lack of effective non-hormonal contraception in females with child-bearing capability (in alendronate group)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has Paget's disease of bone, but is not taking bisphosphonates. Sister had similar problems and was diagnosed with Paget's at age 52.",
  "_meta": {
    "topic_id": "74",
    "trial_id": "NCT01889134",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}